Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.32 |
| ▸ | ICAM1 | P05362 | 4/20 | 0.31 |
| ▸ | SELE | P16581 | 4/20 | 0.31 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17117836 | 0.87 | BCL2L1 (0.36) | KDM4ECLK1LIMK1MAPTRAB9A | |
| SCHEMBL23618535 | 0.80 | EGFR (0.38) | EGFRPIM1PIM2CLK1LIMK1 | |
| SCHEMBL20412000 | 0.79 | CCR1 (0.42) | EGFRPIM1PIM2ACHEKDM4E | |
| SCHEMBL19039366 | 0.77 | PIM1 (0.39) | EGFRPIM1PIM2ACHEKDM4E | |
| SCHEMBL25662799 | 0.77 | IKBKB (0.41) | KDM4ECLK1 | |
| SCHEMBL16919862 | 0.77 | ACHE (0.39) | EGFRPIM1PIM2ACHEKDM4E | |
| SCHEMBL606019 | 0.75 | LIMK1 (0.50) | EGFRLIMK1MAPTRAB9A | |
| SCHEMBL16283905 | 0.75 | NPC1 (0.41) | EGFRPIM1PIM2ACHEKDM4E | |
| SCHEMBL22483136 | 0.74 | CYP2A6 (0.33) | PIM1CLK1LIMK1 | |
| SCHEMBL22483175 | 0.73 | EGFR (0.39) | EGFRKDM4ELIMK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-10957861-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-23 | — | — | US | disclosed |
| EP-2910555-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORP (US) | 2019-03-27 | — | — | EP | disclosed |
| US-10208026-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-02-19 | — | — | US | disclosed |
| US-9755159-B2 | Organic materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| US-20170186977-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-06-29 | — | — | US | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150243893-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| EP-2910555-A1 | Organic electroluminescent materials and devices | Universal Display Corporation (US) | 2015-08-26 | — | — | EP | disclosed |
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | OCIAD1, OCIAD2, SLC25A21 | EGFR 4702/4885PIM1 3421/4885PIM2 3477/4885 |
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | CHRM1, CHRM2, CHRM4 | EGFR 1917/4885PIM1 4619/4885PIM2 4388/4885 |
| US-10957861-B2 | Organic electroluminescent materials and devices | KYNU, ECI1, INMT | EGFR 1785/4885PIM1 599/4885PIM2 688/4885 |
| US-10208026-B2 | Organic electroluminescent materials and devices | ZYX, LBR, LOXL1 | EGFR 1628/4885PIM1 4126/4885PIM2 4033/4885 |
| US-20170186977-A1 | Organic Electroluminescent Materials and Devices | KYNU, EML4, INMT | EGFR 3422/4885PIM1 580/4885PIM2 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.